新生児集中治療用呼吸器機器の世界市場規模：機器タイプ別、エンドユーザー別、地域範囲別および予測

新生児集中治療用呼吸器機器の市場規模と予測

新生児集中治療用呼吸器機器市場規模は、2024年に137億2,000万米ドルと評価され、2026～2032年の予測期間にCAGR 3.66%で、2032年には178億2,000万米ドルに達すると予測されます。

新生児集中治療用呼吸器機器として知られる特殊な医療機器は、未熟児や重症の新生児の呼吸機能をサポートするように設計されています。これらの機器には、人工呼吸器機器、持続的気道陽圧（CPAP）装置、酸素供給システムなどが含まれます。

新生児集中治療室（NICU）では、新生児の呼吸困難を管理するために、新生児集中治療用呼吸器機器が不可欠です。新生児集中治療室（NICU）では、新生児の呼吸困難に対処するために、新生児集中治療呼吸器機器（NICU）が不可欠です。

呼吸窮迫症候群、未熟児無呼吸、気管支肺異形成などの状態にある新生児には、これらの装置によって重要な呼吸補助が提供されます。肺機能のサポートと呼吸パターンの安定化が促進され、リスクのある新生児の全体的な転帰の改善につながります。

今後予想される技術の向上により、新生児集中治療用呼吸器機器装置の効率と機能性が改善され、臨床転帰の改善につながることが期待されます。先進的モニタリング機能と自動化機能の統合が次世代機器の開発を促進し、新生児への優れたケアを保証するものと考えられます。

新生児集中治療用呼吸器機器の世界市場力学

新生児集中治療用呼吸器機器の世界市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

早産児の増加：早産児の増加：世界の早産児の増加率は、新生児用呼吸装置市場の重要な促進要因です。未熟児は肺が未発達であることが多く、呼吸を補助するために気泡式持続気道陽圧（CPAP）システムや機械式人工呼吸器機器などの特殊な呼吸補助装置を使用する必要があります。このように早産新生児における呼吸補助の必要性が高まっていることは、新生児医療における先進的呼吸補助装置の重要な役割を強調しています。

RDSに対する認識の高まり：新生児に最も多い肺疾患であり、新生児集中治療室（NICU）における死亡の主要原因である呼吸窮迫症候群（RDS）に対する認識の高まりが、先進的呼吸器機器ソリューションに対する需要をさらに高めています。ヘルスケアプロバイダや保護者がRDSに関する知識を深めるにつれ、この状態を管理・治療するための効果的で信頼性の高い呼吸器機器の入手が重視されるようになっています。

技術の進歩：このセグメントの技術革新により、モニタリング機能の強化、非侵襲的換気技術、患者の快適性を向上させる小型化設計の機器が開発されています。このような技術的改良は、新生児呼吸ケアの有効性を高めるだけでなく、新生児のデリケートなニーズに対応するため、より使いやすく、より適応しやすい機器となっています。

低侵襲手術：新生児医療における低侵襲手技の動向も、先進的呼吸器機器の採用を促進する重要な要因です。低侵襲手技は、患者の不快感や合併症のリスクを軽減することを目的としています。高流量鼻カニューレ（HFNC）や気泡CPAPシステムなどの機器は、従来型機械的人工呼吸に比べて侵襲性の低い呼吸サポートを提供するため、新生児ケアの現場でますます人気の選択肢となっています。

政府の取り組みと償還：政府の取り組みと支援的な償還施策は、新生児呼吸器機器市場の成長を促進する上で重要な役割を果たしています。新生児ヘルスケアインフラを改善する取り組みは、呼吸器機器に対する有利な償還フレームワークと相まって、先進的新生児ケアへのアクセシビリティを高めています。こうした政府支援イニシアティブにより、病院やクリニックが最先端の呼吸補助技術を提供できるようになり、呼吸補助を必要とする新生児の転帰が改善されます。

主要課題

厳しい規制：新しい医療機器の承認を規定する厳しい規制の枠組みも、市場参入を妨げ、新生児向けの先進的呼吸器機器技術の利用を遅らせる可能性があります。こうした規制は、患者の安全性と機器の有効性を確保するために不可欠である一方で、革新的なソリューションの導入を遅らせる可能性があります。厳格な安全基準の必要性と新技術の迅速な展開のバランスをとることは、規制機関にとってもメーカーにとっても、依然として重要な検討事項です。

熟練労働力の不足：先進的新生児呼吸器機器装置の操作と保守の訓練を受けた熟練ヘルスケア専門家の不足。これらの先進的機器を効果的に使用するには、専門的な訓練と専門知識が必要です。訓練を受けた人材が不足している地域では、これらの技術の潜在的な利点が十分に発揮されない可能性があり、新生児医療への影響が制限されます。

院内感染のリスク：NICUの新生児は、特に院内感染（院内感染）にかかりやすいです。呼吸器機器の使用は、適切な滅菌と感染制御プロトコールが厳守されない場合、これらの感染症のリスクを増大させています。感染症のリスクを最小限に抑え、脆弱な患者の健康を守るためには、呼吸器機器の厳格な衛生管理と定期的なメンテナンスを徹底することが極めて重要です。

新興諸国での入手の困難さ：新興諸国では、先進的な新生児用呼吸器機器装置の高価格と、訓練を受けたヘルスケア要員の不足が、利用への大きな障壁となっています。これらの要因により、救命技術の利用可能性と利用率に格差が生じており、費用対効果の高い解決策と、現地の能力向上を目的としたイニシアチブの必要性が浮き彫りになっています。これらの課題に対処するには、手頃な価格の機器の開発、トレーニングプログラムへの投資、低リソース環境におけるヘルスケアインフラを支援するための国際協力など、多面的なアプローチが必要です。

主要動向

早期発見と早期介入：新生児の呼吸器機器疾患に対する早期診断と早期介入は、予後を改善する上で極めて重要です。現在の動向は、継続的なモニタリングと呼吸困難の早期発見を可能にする機器の開発に重点を置いています。このような先進的モニタリングシステムは、呼吸器機器系の問題の徴候を速やかに発見し、ヘルスケアプロバイダがより迅速かつ効果的に介入できるように設計されています。早期発見技術は、合併症を予防し、呼吸困難のある新生児の全体的な予後を改善し、タイムリーで適切なケアを保証するのに役立ちます。

遠隔医療の統合：遠隔医療ソリューションを新生児呼吸器機器ケアに統合することで、特に新生児集中治療室（NICU）へのアクセスが限られている地域では、ケアの提供方法が変わりつつあります。遠隔医療は、遠隔モニタリングや専門医との協議を可能にし、患者と専門家によるケアのギャップを埋めています。遠隔医療を活用することで、ヘルスケアプロバイダはリアルタイムのサポートや指導を提供することができ、遠隔地や十分なサービスを受けていない地域の新生児ケアの質を向上させることができます。この統合は、専門的ケアへのアクセスを向上させるだけでなく、継続的なモニタリングをサポートし、苦痛の兆候があれば速やかに対処できるようにします。

在宅呼吸器機器サポート：技術の進歩により、安定した新生児に在宅呼吸サポートを提供する傾向が高まっています。このシフトには、家庭環境に適した携帯可能で使いやすい機器の開発が必要です。在宅呼吸器機器サポートにより、両親は慣れ親しんだ環境で新生児をケアすることができ、入院期間と関連コストを削減することができます。これらのポータブル機器は使いやすく設計されており、保護者が自宅で効果的かつ安全に乳児の呼吸器機器管理を行えるようにする一方で、必要な場合には専門医のサポートを受けることができます。

患者の快適性と移動性：患者の不快感を最小限に抑え、移動性を促進することは、新生児ケアにおいて不可欠な考慮事項です。新しい動向は、患者の動きをより大きくし、制限を最小限にする呼吸器機器装置の開発に重点を置いています。これらの技術革新は、呼吸補助方法の侵襲性を低減し、より自然な動きを可能にすることで、新生児の快適性を高めることを目的としています。患者の可動性の向上は、身体発育の向上に寄与するだけでなく、全体的な幸福感を高めるため、現代の新生児呼吸ケアの重要な側面となっています。

AIの統合：人工知能（AI）は、先進的データ分析と意思決定支援を提供することで、新生児呼吸器機器ケアに革命をもたらす態勢を整えています。AIアルゴリズムは、膨大な量の患者データを分析してパターンを特定し、潜在的な呼吸器機器問題を予測することで、臨床医に最適な呼吸器機器サポート戦略に関する洞察を提供することができます。AIを活用することで、ヘルスケアプロバイダはより多くの情報に基づいた意思決定を行い、治療計画を個別化し、呼吸器機器疾患を持つ新生児の転帰を改善できる可能性があります。呼吸ケアシステムへのAIの統合は、新生児ケアの精度と有効性における大きな飛躍を意味します。

持続可能性の重視：環境に優しくエネルギー効率の高い新生児呼吸器機器の開発がますます重視されています。この持続可能性の焦点は、長期的に責任ある資源管理とコスト削減を促進することを目的としています。メーカー各社は、リサイクル可能な材料の使用やエネルギー効率の高いシステムの設計など、環境負荷の少ない機器を開発する方法を模索しています。こうした努力は、世界の持続可能性目標を支援するだけでなく、ヘルスケア施設の運営コストを削減し、先進的呼吸器機器ケアをより身近で安価なものにします。

目次

第1章 世界の新生児集中治療用呼吸器機器市場の導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 新生児集中治療用呼吸器機器の世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 新生児集中治療用呼吸器機器の世界市場：機器タイプ別

• 概要
• ネブライザー
• 吸入器
• 人工呼吸器機器
• 持続陽圧呼吸器機器
• 無呼吸モニター
• その他

第6章 新生児集中治療用呼吸器機器の世界市場：エンドユーザー別

• 概要
• NICU病院
• 専門クリニック
• 介護施設
• その他

第7章 新生児集中治療用呼吸器機器の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の新生児集中治療呼吸器機器市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第9章 企業プロファイル

• Getinge AB
• GE Healthcare
• Vyaire Medical Inc.（BD）
• Teleflex Incorporated
• Medtronic plc
• Mercury Medical
• Dragerwerk AG & Co. KGaA
• Dickinson & Company
• Inspiration Healthcare Group plc
• Trudell Medical International

第10章 主要開発

• 製品上市/開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Neonatal Intensive Care Respiratory Devices Market Size And Forecast

The Neonatal Intensive Care Respiratory Devices Market size was valued to be USD 13.72 Billion in the year 2024 and it is expected to reach USD 17.82 Billion in 2032, at a CAGR of 3.66% over the forecast period of 2026 to 2032.

Specialized medical equipment known as neonatal intensive care respiratory devices are designed to support the respiratory function of premature and critically ill newborns. Included in these devices are ventilators, continuous positive airway pressure (CPAP) machines, and oxygen delivery systems.

Essential utilization of neonatal intensive care respiratory devices occurs in neonatal intensive care units (NICUs) for managing respiratory distress in newborns. Adequate oxygenation and ventilation support are ensured for infants during critical periods through the implementation of these devices.

Vital respiratory assistance is provided by these devices to neonates experiencing conditions such as respiratory distress syndrome, apnea of prematurity, and bronchopulmonary dysplasia. Support for lung function and stabilization of breathing patterns is facilitated, leading to improved overall outcomes for at-risk infants.

Anticipated enhancements in technology are expected to improve the efficiency and functionality of neonatal intensive-care respiratory devices, leading to better clinical outcomes. Integration of advanced monitoring and automation features is likely to drive the development of next-generation devices, ensuring superior care for neonates.

Global Neonatal Intensive Care Respiratory Devices Market Dynamics

The key market dynamics that are shaping the global neonatal intensive care respiratory devices market include:

Key Market Drivers:

Rising Preterm Births: The rising incidence of preterm births globally is a significant driver for the neonatal respiratory devices market. Premature infants often have underdeveloped lungs, necessitating the use of specialized respiratory support devices such as bubble continuous positive airway pressure (CPAP) systems and mechanical ventilators to assist their breathing. This growing need for respiratory assistance in preterm newborns underscores the critical role of advanced respiratory devices in neonatal care.

Growing Awareness of RDS: Increased awareness of respiratory distress syndrome (RDS), the most common lung disorder in newborns and a leading cause of mortality in neonatal intensive care units (NICUs), further fuels demand for advanced respiratory solutions. As healthcare providers and parents become more informed about RDS, there is a heightened emphasis on obtaining effective and reliable respiratory devices to manage and treat this condition.

Technological Advancements: Innovations in this field have resulted in devices with enhanced monitoring capabilities, non-invasive ventilation techniques, and miniaturized designs that improve patient comfort. These technological improvements not only enhance the effectiveness of neonatal respiratory care but also ensure that the devices are easier to use and more adaptable to the delicate needs of newborns.

Minimally Invasive Procedures: The trend towards minimally invasive procedures in neonatal care is another key factor driving the adoption of advanced respiratory devices. Minimally invasive techniques aim to reduce patient discomfort and the risk of complications. Devices such as high-flow nasal cannula (HFNC) and bubble CPAP systems offer less invasive respiratory support compared to traditional mechanical ventilation, making them increasingly popular choices in neonatal care settings.

Government Initiatives and Reimbursement: Government initiatives and supportive reimbursement policies play a crucial role in driving the growth of the neonatal respiratory devices market. Efforts to improve neonatal healthcare infrastructure, coupled with favorable reimbursement frameworks for respiratory devices, enhance accessibility to advanced neonatal care. These government-supported initiatives ensure that hospitals and clinics can provide state-of-the-art respiratory support technologies, thereby improving outcomes for newborns requiring respiratory assistance.

Key Challenges:

Stringent Regulations: Stringent regulatory frameworks governing the approval of new medical devices can also impede market entry and delay the availability of advanced respiratory technologies for newborns. While these regulations are essential for ensuring patient safety and device efficacy, they can slow down the introduction of innovative solutions. Balancing the need for rigorous safety standards with the rapid deployment of new technologies remains a critical consideration for regulatory bodies and manufacturers alike.

Skilled Workforce Shortages: Lack of skilled healthcare professionals trained to operate and maintain sophisticated neonatal respiratory devices. The effective use of these advanced devices requires specialized training and expertise. In regions where there is a lack of trained personnel, the potential benefits of these technologies may not be fully realized, limiting their impact on neonatal care.

Nosocomial Infection Risk: Neonates in NICUs are particularly vulnerable to nosocomial, or hospital-acquired, infections. The use of respiratory devices increases the risk of these infections if proper sterilization and infection control protocols are not strictly followed. Ensuring rigorous hygiene practices and regular maintenance of respiratory equipment is crucial to minimizing the risk of infections and safeguarding the health of these vulnerable patients.

Limited Availability in Developing Countries: In developing countries, the high cost of advanced neonatal respiratory devices and the scarcity of trained healthcare personnel present substantial barriers to access. These factors contribute to a disparity in the availability and utilization of life-saving technologies, highlighting the need for cost-effective solutions and initiatives aimed at building local capacity. Addressing these challenges requires a multifaceted approach, including the development of affordable devices, investment in training programs, and international collaboration to support healthcare infrastructure in low-resource settings.

Key Trends:

Early Detection and Intervention: Early diagnosis and intervention for respiratory problems in newborns are crucial for improving outcomes. Current trends focus on the development of devices that provide continuous monitoring and early detection of respiratory distress. These advanced monitoring systems are designed to promptly identify signs of respiratory issues, allowing healthcare providers to intervene more quickly and effectively. Early detection technologies can help prevent complications and improve the overall prognosis for neonates with respiratory challenges, ensuring timely and appropriate care.

Telemedicine Integration: Integrating telemedicine solutions with neonatal respiratory care is transforming how care is delivered, particularly in regions with limited access to neonatal intensive care units (NICUs). Telemedicine enables remote monitoring and consultations with specialists, bridging the gap between patients and expert care. By utilizing telemedicine, healthcare providers can offer real-time support and guidance, improving the quality of care for newborns in remote or underserved areas. This integration not only enhances access to specialized care but also supports continuous monitoring, ensuring that any signs of distress are addressed promptly.

Home-Based Respiratory Support: Technological advancements are driving a growing trend toward providing home-based respiratory support for stable neonates. This shift requires the development of portable and user-friendly devices suitable for home settings. Home-based respiratory support allows parents to care for their infants in a familiar environment, which can reduce hospital stays and associated costs. These portable devices are designed to be easy to use, ensuring that parents can manage their infants' respiratory needs effectively and safely at home, while still having access to professional medical support when needed.

Patient Comfort and Mobility: Minimizing patient discomfort and promoting mobility are essential considerations in neonatal care. New trends focus on developing respiratory devices that allow for greater patient movement and minimize restrictions. These innovations aim to enhance the comfort of neonates by reducing the invasiveness of respiratory support methods and allowing for more natural movement. Improved patient mobility not only contributes to better physical development but also enhances overall well-being, making it a critical aspect of modern neonatal respiratory care.

AI Integration: Artificial intelligence (AI) is poised to revolutionize neonatal respiratory care by offering advanced data analysis and decision-making support. AI algorithms can analyze vast amounts of patient data to identify patterns and predict potential respiratory issues, providing clinicians with insights into optimal respiratory support strategies. By leveraging AI, healthcare providers can make more informed decisions, personalize treatment plans, and potentially improve outcomes for neonates with respiratory conditions. The integration of AI into respiratory care systems represents a significant leap forward in the precision and effectiveness of neonatal care.

Sustainability Focus: There is an increasing emphasis on developing environmentally friendly and energy-efficient neonatal respiratory devices. This sustainability focus aims to promote responsible resource management and cost reduction in the long term. Manufacturers are exploring ways to create devices that have a lower environmental impact, such as using recyclable materials and designing energy-efficient systems. These efforts not only support global sustainability goals but also reduce operational costs for healthcare facilities, making advanced respiratory care more accessible and affordable.

Global Neonatal Intensive Care Respiratory Devices Market Regional Analysis

Here is a more detailed regional analysis of the global neonatal intensive care respiratory devices market:

North America:

North America is substantially dominating the Global Neonatal Intensive Care Respiratory Devices Market and is expected to continue its dominance throughout the forecast period.

North America is a leader in the neonatal respiratory devices market, thanks to its advanced healthcare infrastructure, which includes a high concentration of specialized neonatal intensive care units (NICUs) equipped with cutting-edge respiratory devices.

The region experiences a relatively high rate of preterm births, which significantly increases the demand for respiratory support for neonates.

Efforts to prevent preterm births are ongoing, yet advancements in neonatal care have notably improved the survival rates of premature infants, further necessitating the need for sophisticated respiratory aid.

Supportive government policies and robust healthcare reimbursement systems play a crucial role in ensuring hospitals have access to the latest respiratory technologies. These policies facilitate the procurement of advanced devices, enhancing the quality of neonatal care.

Furthermore, North America's status as a hub for medical research and development fosters the creation of innovative neonatal respiratory devices, keeping the region at the forefront of technological advancements in healthcare.

The market dynamics in North America are characterized by high adoption rates of new and advanced neonatal respiratory devices, driven by the region's focus on technological innovation and improving neonatal outcomes.

There is a growing preference for minimally invasive respiratory support options, such as High Flow Nasal Cannula (HFNC), which are designed to minimize discomfort for neonates while providing effective respiratory assistance.

The presence of major companies like Philips, ResMed, and GE Healthcare dominates the North American market, driving continuous innovation and competition. These key players' commitment to developing advanced, user-friendly, and minimally invasive respiratory solutions ensures that North America remains a leader in the neonatal respiratory devices market.

Asia Pacific

The Asia Pacific (APAC) region is expected to experience the fastest growing region Global Neonatal Intensive Care Respiratory Devices Market, driven by rapidly developing economies in the region are leading to increased healthcare spending and substantial investments in enhancing neonatal care infrastructure.

This economic progress translates into a growing demand for advanced respiratory devices in neonatal intensive care units (NICUs).

Coupled with rising birth rates and an increasing number of preterm births, there is a larger patient pool requiring specialized respiratory support. This demographic trend underscores the critical need for effective neonatal respiratory care solutions.

Government initiatives across many APAC countries are prioritizing maternal and child healthcare improvements.

These initiatives include allocating funds to upgrade NICUs and equip them with essential respiratory devices, reflecting a strong commitment to improving neonatal outcomes. Such government support not only enhances the quality of care but also boosts the demand for advanced medical technologies.

While there is a growing market for high-end respiratory devices, affordability remains a crucial concern in many APAC countries. This creates a dual market dynamic where there is significant demand for both premium and cost-effective respiratory devices.

Manufacturers are thus incentivized to develop and offer a range of products that cater to diverse economic segments, ensuring broader access to life-saving technologies.

Market dynamics in the APAC region are also influenced by a surge in domestic production of neonatal respiratory devices. Factors such as lower manufacturing costs and a focus on self-reliance are driving this trend.

Domestic production not only meets local demand more efficiently but also supports regional economic growth and innovation.

Additionally, there is an increasing emphasis on early detection and intervention of neonatal respiratory problems. This proactive approach leads to a greater need for advanced and effective respiratory support technologies.

Early detection devices and interventions are essential in managing respiratory distress promptly, improving survival rates, and reducing long-term health complications for newborns.

Collectively, these factors are shaping a vibrant and rapidly expanding neonatal respiratory devices market in the Asia Pacific region.

Global Neonatal Intensive Care Respiratory Devices Market: Segmentation Analysis

The Global Neonatal Intensive Care Respiratory Devices Market is segmented based on Device Type, End-User, And Geography.

Neonatal Intensive Care Respiratory Devices Market, By Device Type

• Nebulizers
• Inhalers
• Ventilators
• Continuous Positive Airway Devices
• Apnea Monitors

Based on Device Type, the Neonatal Intensive Care Respiratory Devices Market is segmented into Nebulizers, Inhalers, Ventilators, Continuous Positive Airway Devices, and Apnea Monitors. The Inhalers segment is experiencing significant growth in the Global Neonatal Intensive Care Respiratory Devices Market, owing to the increasing incidence of severe respiratory cases linked to extreme pollution levels. As pollution continues to escalate worldwide, leading to a gradual decline in the Air Quality Index, the demand for inhalers is expected to rise. This sector is anticipated to record higher sales in the coming years as healthcare providers seek effective solutions to manage and treat respiratory conditions in neonates affected by poor air quality.

Neonatal Intensive Care Respiratory Devices Market, By End-User

• NICU Hospitals
• Specialty Clinics
• Nursing Homes

Based on End-User, the Neonatal Intensive Care Respiratory Devices Market is segmented into NICU Hospitals, Specialty Clinics, and Nursing Homes. The NICU Hospitals segment is showing significant growth in the Global Neonatal Intensive Care Respiratory Devices Market owing to the increase in the number of premature births occurring in recent times. Owing to the number of premature births, the need for NICU facilities is becoming inevitable most of the time. It is further expected to expand.

Neonatal Intensive Care Respiratory Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Regional Analysis, the Global Neonatal Intensive Care Respiratory Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is substantially dominating the Global Neonatal Intensive Care Respiratory Devices Market and is expected to continue its dominance throughout the forecast period. North America is a leader in the neonatal respiratory devices market, thanks to its advanced healthcare infrastructure, which includes a high concentration of specialized neonatal intensive care units (NICUs) equipped with cutting-edge respiratory devices. The region experiences a relatively high rate of preterm births, which significantly increases the demand for respiratory support for neonates. Efforts to prevent preterm births are ongoing, yet advancements in neonatal care have notably improved the survival rates of premature infants, further necessitating the need for sophisticated respiratory aid.

Key Players

The "Global Neonatal Intensive Care Respiratory Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Getinge AB, GE Healthcare, Vyaire Medical Inc. (BD), Teleflex Incorporated, Medtronic plc, Mercury Medical, Dragerwerk AG & Co. KGaA, Dickinson & Company, Inspiration Healthcare Group plc, and Trudell Medical International. Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Global Neonatal Intensive Care Respiratory Devices Market Key Developments

• In June 2020, Inspiration Healthcare plc paid £18 million to SLE, a provider of newborn ventilation products, following a successful funding round.
• In April 2020, during the COVID-19 pandemic, Philips debuted its readily available ventilation option, the Philips Respironics E30 ventilator. It would benefit clinics and hospitals that do not have critical care, full-featured ventilators.
• In April 2019, InnAccel announced SAANS, the world's first portable, infrastructure-independent newborn CPAP machine. It will aid critically unwell infants with RDS by providing breathing support.
• In April 2019, Dragerwerk AG & Co. KGaA gained FDA approval for the Seattle Positive Airway Pressure Plus System for neonates with respiratory distress syndrome.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY DEVICE TYPE

• 5.1 Overview
• 5.2 Nebulizers
• 5.3 Inhalers
• 5.4 Ventilators
• 5.5 Continuous Positive Airway Devices
• 5.5 Apnea Monitors
• 5.6 Others

6 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY END-USER

• 6.1 Overview
• 6.2 NICU Hospitals
• 6.3 Specialty Clinics
• 6.4 Nursing Homes
• 6.5 Other

7 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL NEONATAL INTENSIVE CARE RESPIRATORY DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Getinge AB
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Business Breakdown
  • 9.1.4 Product Benchmarking
  • 9.1.5 Key Developments
  • 9.1.6 Winning Imperatives
  • 9.1.7 Current Focus & Strategies
  • 9.1.8 Threat from Competition
  • 9.1.9 SWOT Analysis
• 9.2 GE Healthcare
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Business Breakdown
  • 9.2.4 Product Benchmarking
  • 9.2.5 Key Developments
  • 9.2.6 Winning Imperatives
  • 9.2.7 Current Focus & Strategies
  • 9.2.8 Threat from Competition
  • 9.2.9 SWOT Analysis
• 9.3 Vyaire Medical Inc. (BD)
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Business Breakdown
  • 9.3.4 Product Benchmarking
  • 9.3.5 Key Developments
  • 9.3.6 Winning Imperatives
  • 9.3.7 Current Focus & Strategies
  • 9.3.8 Threat from Competition
  • 9.3.9 SWOT Analysis
• 9.4 Teleflex Incorporated
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Business Breakdown
  • 9.4.4 Product Benchmarking
  • 9.4.5 Key Developments
  • 9.4.6 Winning Imperatives
  • 9.4.7 Current Focus & Strategies
  • 9.4.8 Threat from Competition
  • 9.4.9 SWOT Analysis
• 9.5 Medtronic plc
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Business Breakdown
  • 9.5.4 Product Benchmarking
  • 9.5.5 Key Developments
  • 9.5.6 Winning Imperatives
  • 9.5.7 Current Focus & Strategies
  • 9.5.8 Threat from Competition
  • 9.5.9 SWOT Analysis
• 9.6 Mercury Medical
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Business Breakdown
  • 9.6.4 Product Benchmarking
  • 9.6.5 Key Developments
  • 9.6.6 Winning Imperatives
  • 9.6.7 Current Focus & Strategies
  • 9.6.8 Threat from Competition
  • 9.6.9 SWOT Analysis
• 9.7 Dragerwerk AG & Co. KGaA,
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Business Breakdown
  • 9.7.4 Product Benchmarking
  • 9.7.5 Key Developments
  • 9.7.6 Winning Imperatives
  • 9.7.7 Current Focus & Strategies
  • 9.7.8 Threat from Competition
  • 9.7.9 SWOT Analysis
• 9.8 Dickinson & Company
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Business Breakdown
  • 9.8.4 Product Benchmarking
  • 9.8.5 Key Developments
  • 9.8.6 Winning Imperatives
  • 9.8.7 Current Focus & Strategies
  • 9.8.8 Threat from Competition
  • 9.8.9 SWOT Analysis
• 9.9 Inspiration Healthcare Group plc
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Business Breakdown
  • 9.9.4 Product Benchmarking
  • 9.9.5 Key Developments
  • 9.9.6 Winning Imperatives
  • 9.9.7 Current Focus & Strategies
  • 9.9.8 Threat from Competition
  • 9.9.9 SWOT Analysis
• 9.10 Trudell Medical International
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Business Breakdown
  • 9.10.4 Product Benchmarking
  • 9.10.5 Key Developments
  • 9.10.6 Winning Imperatives
  • 9.10.7 Current Focus & Strategies
  • 9.10.8 Threat from Competition
  • 9.10.9 SWOT Analysis

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research